Profil
Katie Sullivan is currently working as the Senior Director-Corporate Communications at Gelesis, Inc. since 2020.
Prior to this, she worked as the Head-Media Contact at Gelesis Holdings, Inc.
Aktive Positionen von Katie Sullivan
| Unternehmen | Position | Beginn |
|---|---|---|
| GELESIS INC | Public Communications Contact | 01.02.2020 |
Ehemalige bekannte Positionen von Katie Sullivan
| Unternehmen | Position | Ende |
|---|---|---|
| GELESIS HOLDINGS, INC. | Public Communications Contact | 30.10.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GELESIS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |